Loading...

Noriko Satake

TitleAsst Prof
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. Pediatr Res. 2017 Sep; 82(3):527-535. PMID: 28419087.
      View in: PubMed
    2. Yoshida S, Tuscano E, Duong C, Chung J, Li Y, Beckett L, Tuscano JM, Satake N. Efficacy of an anti-CD22 antibody-monomethyl auristatin E conjugate in a preclinical xenograft model of precursor B-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2017 05; 58(5):1254-1257. PMID: 27701909.
      View in: PubMed
    3. Satake N, Duong C, Yoshida S, Oestergaard M, Chen C, Peralta R, Guo S, Seth PP, Li Y, Beckett L, Chung J, Nolta J, Nitin N, Tuscano JM. Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate. Mol Med. 2016 Jul 22; 22. PMID: 27455414.
      View in: PubMed
    4. Barisone GA, Satake N, Lewis C, Duong C, Chen C, Lam KS, Nolta J, D?az E. Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells. Blood Cells Mol Dis. 2015 Apr; 54(4):329-35. PMID: 25554682; PMCID: PMC4387021.
    5. Satake N, Duong C, Chen C, Barisone GA, Diaz E, Tuscano J, Rocke DM, Nolta J, Nitin N. Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia. Br J Haematol. 2014 Nov; 167(4):487-99. PMID: 25196579.
      View in: PubMed
    6. Liu R, Mao Z, Matthews DL, Li CS, Chan JW, Satake N. Novel single-cell functional analysis of red blood cells using laser tweezers Raman spectroscopy: application for sickle cell disease. Exp Hematol. 2013 Jul; 41(7):656-661.e1. PMID: 23537725.
      View in: PubMed
    7. Kato J, Satake N, O'Donnell RT, Abuhay M, Lewis C, Tuscano JM. Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia. Leuk Res. 2013 Jan; 37(1):83-8. PMID: 23040543.
      View in: PubMed
    8. Thampi S, Salmi D, Imashuku S, Ducore J, Satake N. Thrombotic thrombocytopenic purpura in a child with systemic lupus erythematosus. J Pediatr Hematol Oncol. 2011 Apr; 33(3):221-3. PMID: 21336165.
      View in: PubMed
    9. Salmi D, Patel C, Imashuku S, Shimada H, Satake N. Neuroblastoma of unknown primary site with periorbital bone metastasis in a child. Pediatr Blood Cancer. 2010 Aug; 55(2):361-3. PMID: 20582979.
      View in: PubMed
    10. Marsh RA, Satake N, Biroschak J, Jacobs T, Johnson J, Jordan MB, Bleesing JJ, Filipovich AH, Zhang K. STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America. Pediatr Blood Cancer. 2010 Jul 15; 55(1):134-40. PMID: 20486178.
      View in: PubMed
    11. Salmi D, Bhat A, Corman L, Raff G, Satake N. Diagnostic challenges in native valve fungal endocarditis producing a massive septic pulmonary embolus. Nihon Ishinkin Gakkai Zasshi. 2010; 51(4):207-10. PMID: 21060214.
      View in: PubMed
    12. Kimura Y, Sumiyoshi M, Samukawa K, Satake N, Sakanaka M. Facilitating action of asiaticoside at low doses on burn wound repair and its mechanism. Eur J Pharmacol. 2008 Apr 28; 584(2-3):415-23. PMID: 18353310.
      View in: PubMed
    13. Zheng Y, Rozengurt N, Ryazantsev S, Kohn DB, Satake N, Neufeld EF. Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow. Mol Genet Metab. 2003 Aug; 79(4):233-44. PMID: 12948739.
      View in: PubMed